Global Beta-Nicotinamide Mononucleotide (NMN) Market Growth 2025-2031

Global Beta-Nicotinamide Mononucleotide (NMN) Market Growth 2025-2031

The global Beta-Nicotinamide Mononucleotide (NMN) market size is predicted to grow from US$ 409 million in 2025 to US$ 890 million in 2031; it is expected to grow at a CAGR of 13.8% from 2025 to 2031.

Nicotinamide mononucleotide (NMN) is an intermediate of NAD+ biosynthesis produced from nicotinamide through nicotinamide phosphoribosyltransferase (NAMPT) and also referred to as NMN or nicotinamide ribotide. In recent studies of NMN applications to prevention and diagnosis of age-dependent diseases such as diabetes, neurodegenerative disorder, cardiac disease etc., it has become one of hottest biomarkers on discussion for anti-aging, lately.

NMN is a precursor of nicotinamide adenine dinucleotide (NAD+), which plays a vital role in cell metabolism and energy production. As we age, the level of NAD+ in the human body gradually decreases, resulting in weakened cell metabolism, which in turn triggers a series of aging-related diseases. Therefore, increasing the level of NAD+ in the body by supplementing NMN has become a new way to fight aging and maintain good health.

With the general improvement of global health awareness and continuous breakthroughs in scientific research and technology, the growth momentum of the NMN market will continue to increase. In the future, the NMN market will achieve a deeper cross-border integration with other health industries such as biotechnology, precision medicine, and nutritional supplements, giving rise to a series of innovative products and service models to meet consumers' more personalized and precise health needs.

At present, nicotinamide mononucleotide (NMN) is still in the development stage. There are not many manufacturers in the global market, and consumers have weak awareness of its use, especially in developing countries. The demand is lower than that in developed countries around the world, but the demand in developing countries is growing rapidly. Leading giants have proposed expansion plans and increased production bases.

Nicotinamide mononucleotide (NMN) core manufacturers include GeneHarbor, Mirailab Bioscience, Maac10 Formulas, Herbalmax and Genex Formula. China is the largest production area, accounting for about 84% of the global market share, followed by North America and Japan. The downstream applications of nicotinamide mononucleotide include health products, cosmetics, etc. Globally, health products are the largest application market, and raw materials for health products account for 99% of the total sales of nicotinamide mononucleotide in 2023.

LP Information, Inc. (LPI) ' newest research report, the “Beta-Nicotinamide Mononucleotide (NMN) Industry Forecast” looks at past sales and reviews total world Beta-Nicotinamide Mononucleotide (NMN) sales in 2024, providing a comprehensive analysis by region and market sector of projected Beta-Nicotinamide Mononucleotide (NMN) sales for 2025 through 2031. With Beta-Nicotinamide Mononucleotide (NMN) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Beta-Nicotinamide Mononucleotide (NMN) industry.

This Insight Report provides a comprehensive analysis of the global Beta-Nicotinamide Mononucleotide (NMN) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Beta-Nicotinamide Mononucleotide (NMN) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Beta-Nicotinamide Mononucleotide (NMN) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Beta-Nicotinamide Mononucleotide (NMN) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Beta-Nicotinamide Mononucleotide (NMN).

This report presents a comprehensive overview, market shares, and growth opportunities of Beta-Nicotinamide Mononucleotide (NMN) market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Content ≥98%
Content ＜98%

Segmentation by Application:
Health Care Products
Cosmetics
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
GeneHarbor
Herbalmax
Genex Formulas
Mirailab Bioscience
Maac10 Formulas
EffePharm
Bontac
CELFULL
Kingdomway
ABA Chemical

Key Questions Addressed in this Report

What is the 10-year outlook for the global Beta-Nicotinamide Mononucleotide (NMN) market?

What factors are driving Beta-Nicotinamide Mononucleotide (NMN) market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Beta-Nicotinamide Mononucleotide (NMN) market opportunities vary by end market size?

How does Beta-Nicotinamide Mononucleotide (NMN) break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.